Filing Details

Accession Number:
0001209191-20-050083
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-09-10 21:02:19
Reporting Period:
2020-09-08
Accepted Time:
2020-09-10 21:02:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1322505 Albireo Pharma Inc. ALBO () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1213040 J. Martha Carter C/O Albireo Pharma, Inc.
10 Post Office Square, Suite 1000
Boston MA 02109
Chief Regulatory Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-09-08 10,000 $19.19 10,000 No 4 M Direct
Common Stock Disposition 2020-09-08 10,000 $45.55 0 No 4 S Direct
Common Stock Acquisiton 2020-09-09 7,500 $19.19 7,500 No 4 M Direct
Common Stock Acquisiton 2020-09-09 2,500 $24.04 10,000 No 4 M Direct
Common Stock Disposition 2020-09-09 7,500 $38.68 2,500 No 4 S Direct
Common Stock Disposition 2020-09-09 2,500 $39.82 0 No 4 S Direct
Common Stock Acquisiton 2020-09-10 9,312 $24.04 9,312 No 4 M Direct
Common Stock Acquisiton 2020-09-10 688 $24.48 10,000 No 4 M Direct
Common Stock Disposition 2020-09-10 10,000 $42.41 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2020-09-08 10,000 $0.00 10,000 $19.19
Common Stock Stock Option (right to buy) Disposition 2020-09-09 7,500 $0.00 7,500 $19.19
Common Stock Stock Option (right to buy) Disposition 2020-09-09 2,500 $0.00 2,500 $24.04
Common Stock Stock Option (right to buy) Disposition 2020-09-10 9,312 $0.00 9,312 $24.04
Common Stock Stock Option (right to buy) Disposition 2020-09-10 688 $0.00 688 $24.48
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
10,000 2027-01-19 No 4 M Direct
2,500 2027-01-19 No 4 M Direct
29,000 2029-01-21 No 4 M Direct
19,688 2029-01-21 No 4 M Direct
12,312 2027-08-20 No 4 M Direct
Footnotes
  1. Shares sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 20, 2019.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.51 to $38.82, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.06 to $42.70, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
  4. This option vests and become exercisable in equal installments on the last day of 16 consecutive calendar quarters beginning with March 31, 2017 and ending on December 31, 2020.
  5. This option vested as to 25% of the shares on January 22, 2020 with the remainder vesting in equal installments every three months thereafter, beginning on April 22, 2020 and ending on January 22, 2023.
  6. This option vests and become exercisable in equal installments on the last day of 16 consecutive calendar quarters beginning with September 30, 2017 and ending on June 30, 2021.